DXCM
DexCom, Inc. (DXCM)
NASDAQ · Healthcare
DexCom, Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- DexCom, Inc. shareholder equity for the quarter ending December 31, 2025 were 2.75B, a 30.60% increase year-over-year.
- DexCom, Inc. shareholder equity for 2025 were 2.75B, a 30.60% increase from 2024.
- DexCom, Inc. shareholder equity for 2024 were 2.10B, a 1.64% increase from 2023.
- DexCom, Inc. shareholder equity for 2023 were 2.07B, a 2.96% decrease from 2022.
- DexCom, Inc. shareholder equity for 2022 were 2.13B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| DexCom, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $2,746 |
| 2024 | $2,103 |
| 2023 | $2,069 |
| 2022 | $2,132 |
| 2021 | $2,042 |
| 2020 | $1,552 |
| 2019 | $883 |
| 2018 | $663 |
| 2017 | $419 |
| 2016 | $284 |
| 2015 | $221 |
| 2014 | $140 |
| 2013 | $84 |
| 2012 | $77 |
| 2011 | $105 |
| DexCom, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $2,746 |
| 2024-12-31 | $2,103 |
| 2023-12-31 | $2,069 |
| 2022-12-31 | $2,132 |
| 2021-12-31 | $2,042 |
| 2020-12-31 | $1,552 |
| 2019-12-31 | $883 |
| 2018-12-31 | $663 |
| 2017-12-31 | $419 |
| 2016-12-31 | $284 |
| 2015-12-31 | $221 |
| 2014-12-31 | $140 |
| 2013-12-31 | $84 |
| 2012-12-31 | $77 |
| 2011-12-31 | $105 |
| 2010-12-31 | $61 |
DexCom, Inc. Shareholder Equity — FAQ
DexCom, Inc. (DXCM) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DXCM's shareholder equity history?
The chart and table above show DexCom, Inc.'s shareholder equity by year and by quarter, including the growth rate.